Canada Diabetes Care Devices Market - Growth, Trends, and Forecasts (2020 - 2025)

The Market is segmented by Management Devices (Insulin Pumps, Insulin Pens, Syringes, Cartridges, and Jet Injectors) and Monitoring Devices (Self-monitoring Blood Glucose (Hospital and Personal use) and Continuous Glucose Monitoring), and Geography.

Market Snapshot

Study Period:

2012-2024

Base Year:

2019

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

  • The Canada diabetes care devices market is expected to register a CAGR of about 10.02% during the forecast period (2019-2024).
  • Monitoring devices are anticipated to dominate the market during the forecast period, owing to the rising prevalence of diabetes and an increase in the number of device users in the country.
  • There has been a significant rise in insulin delivery systems technology, from insulin injections to insulin pumps.
  • Technological innovations and advances give many conveniences in measuring the blood glucose levels. One such advancement in monitoring the blood glucose levels has established with continuous glucose monitoring devices. 

Scope of the Report

The Market is segmented by Management Devices (Insulin Pumps, Insulin Pens, Syringes, Cartridges, and Jet Injectors) and Monitoring Devices (Self-monitoring Blood Glucose (Hospital and Personal use) and Continuous Glucose Monitoring), and Geography.

By Monitoring DevicesSelf-monitoring Blood Glucose DevicesGlucometer Devices
Blood Glucose Test Strips
Lancets
Hospital
Personal
Continuous Glucose Monitoring DevicesSensors
Receivers
 
By Management DevicesInsulin PumpInsulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes 
Cartridges in Reusable pens
Disposable Insulin Pens
Jet Injectors
By Product
By Monitoring Devices, Value and Volume (2012-2024)
Self-monitoring Blood Glucose Devices
Glucometer Devices
Hospital
Personal
Blood Glucose Test Strips
Hospital
Personal
Lancets
Hospital
Personal
Continuous Glucose Monitoring
Sensors
Receivers
By Management Devices, Value and Volume (2012-2024)
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Insulin Syringes
Cartridges in Reusable pens
Insulin Disposable Pens
Jet Injectors
Geography
Canada (Value and Volume, 2012 - 2024)
By Monitoring Device (Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring)
By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)
By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, and Others)

Report scope can be customized per your requirements. Click here.

Key Market Trends

Test strips occupy the highest market share among the Monitoring devices for the year 2018

  • Monitoring devices include self-monitoring blood glucose devices (SMBG) and continuous glucose monitoring devices (CGM), where SMBG devices had the highest share in 2018, with a revenue of USD 0.2 billion and test strips occupy 0.1 billion.
  • The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient.
  • Type-1 diabetic patients need to check their blood glucose levels at regular intervals, to monitor their blood glucose levels and adjust the insulin dosing accordingly.
  • Therefore, if a patient performs 5-6 tests in a day, the average expenditure on test strips would be more than USD 100/month. These expenses add to the already high diabetes management costs and are impeding market growth.

To understand key trends, Download Sample Report

Insulin Pumps Occupy the Highest Share in the Management Devices Segment

  • The use of Insulin pumps is rising among developed countries. These are the devices which mimic the human pancreas, i.e., there would be continuous subcutaneous insulin administration in small amounts.
  • Insulin pumps deliver rapid- or short-acting insulin 24 hours a day through a catheter placed under the skin.
  • The insulin pumps usage among Canadian patients increased due to the accurate dosage of administration and patients who are not able to meet the insulin requirements accurately.
  • Thus, the CAGR growth is expected to be 4.83% during the forecast period.

To understand geography trends, Download Sample Report.

Competitive Landscape

  • There have been constant innovations driven by manufacturers to compete in the market. The major players, such as Abbott and Medtronic, have undergone many mergers, acquisitions, and partnerships, to establish market dominance, while also adhering to organic growth strategies, which is evident from the R&D spending of these companies.
  • The manufacturers of insulin delivery devices are spending a massive amount on the R&D of the devices. For example, Novo Nordisk partnered with Abbott Diabetes Care, which may help to enable insulin data to be shared between Novo Nordisk connected insulin pens and digital health tools compatible with FreeStyle Libre portfolio of products.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Table Of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Drivers

    3. 4.3 Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Product

      1. 5.1.1 By Monitoring Devices, Value and Volume (2012-2024)

        1. 5.1.1.1 Self-monitoring Blood Glucose Devices

          1. 5.1.1.1.1 Glucometer Devices

            1. 5.1.1.1.1.1 Hospital

            2. 5.1.1.1.1.2 Personal

          2. 5.1.1.1.2 Blood Glucose Test Strips

            1. 5.1.1.1.2.1 Hospital

            2. 5.1.1.1.2.2 Personal

          3. 5.1.1.1.3 Lancets

            1. 5.1.1.1.3.1 Hospital

            2. 5.1.1.1.3.2 Personal

        2. 5.1.1.2 Continuous Glucose Monitoring

          1. 5.1.1.2.1 Sensors

          2. 5.1.1.2.2 Receivers

      2. 5.1.2 By Management Devices, Value and Volume (2012-2024)

        1. 5.1.2.1 Insulin Pump

          1. 5.1.2.1.1 Insulin Pump Device

          2. 5.1.2.1.2 Insulin Pump Reservoir

          3. 5.1.2.1.3 Infusion Set

        2. 5.1.2.2 Insulin Syringes

        3. 5.1.2.3 Cartridges in Reusable pens

        4. 5.1.2.4 Insulin Disposable Pens

        5. 5.1.2.5 Jet Injectors

    2. 5.2 Geography

      1. 5.2.1 Canada (Value and Volume, 2012 - 2024)

        1. 5.2.1.1 By Monitoring Device (Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring)

        2. 5.2.1.2 By Management Device (Insulin Pump, Syringes, Cartridges, Disposable Pens, Jet Injectors)

        3. 5.2.1.3 By Company (Roche, Dexcom, Abbott, Johnson and Johnson, Medtronics, Novo Nordisk, and Others)

  6. 6. MARKET INDICATORS

    1. 6.1 Type 1 Diabetes Population (2012-2024)

    2. 6.2 Type 2 Diabetes Population (2012-2024)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 COMPANY PROFILES

      1. 7.1.1 Abbott Diabetes Care

      2. 7.1.2 Roche

      3. 7.1.3 Johnson & Johnson

      4. 7.1.4 Dexcom

      5. 7.1.5 Medtronic

      6. 7.1.6 Arkray

      7. 7.1.7 Ascensia Diabetes Care

      8. 7.1.8 Agamatrix Inc.

      9. 7.1.9 Novo Nordisk

      10. 7.1.10 Eli Lilly

    2. 7.2 COMPANY SHARE ANALYSIS

      1. 7.2.1 Roche

      2. 7.2.2 Johnson & Johnson

      3. 7.2.3 Abbott Diabetes Care

      4. 7.2.4 Dexcom

      5. 7.2.5 Medtronics

      6. 7.2.6 Novo Nordisk

      7. 7.2.7 Others

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Related Reports